If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

September is Prostate Cancer Awareness Month. This month shines a light on an issue that affects millions of men and individuals assigned male at birth. Prostate cancer is the second most common ...

A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate. The study opens the door to potential new treatments for bacterial ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

At 77 years old, Tyson Johnson has been in treatment for metastatic prostate cancer for more than 20 years. “I’m the healthiest dead man you’ve ever seen,” the Carthage resident said jokingly as he ...